Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 4
Encontrada(s) 1 página(s)

Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Patient-derived preclinical models to develop immunotherapies

  • Seoane, Joan
Immuno-oncology; Preclinical models; Tumor microenvironment, Inmuno-oncología; Modelos preclínicos; Microambiente tumoral, Immuno-oncologia; Models preclínics; Microambient tumoral, Cancer immunotherapy has revolutionized the treatment of some malignancies. Yet, many tumors do not unfortunately respond to immune-based therapies. Deeper insights into the biology of the immune response to cancer are required to identify novel therapeutic targets and advance immuno-oncology. To do so, we need to study cancer in patient-derived models that can faithfully recapitulate and capture the complexity and heterogeneity of the tumor immune ecosystem. Platforms facilitating the analysis of the human tumor immune microenvironment of individual patients are crucial. Patient-derived models are fundamental not only to better understand the biology of the cancer immune system but also to discern the mechanism of action of therapeutic compounds and perform preclinical studies toward improving the success of subsequent clinical testing. In this viewpoint, I present a brief review of patient-derived models for cancer immunotherapy., Fundación Asociación Española Contra el Cáncer (AECC). Cellex Foundation. BBVA (CAIMI). ISCIII FIS. Grant Number: PI22 00130
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Targeting the Warburg Effect in Cancer: Where Do We Stand?

  • Carrillo-Bosch, Laura
  • Barba, Ignasi
  • Seoane, Joan
Warburg effect; Aerobic glycolysis; Tumor metabolism, Efecto Warburg; Glucólisis aeróbica; Metabolismo tumoral, Efecte Warburg; Glucòlisi aeròbica; Metabolisme tumoral, The Warburg effect, characterized by the preferential conversion of glucose to lactate even in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of cancer cells and has emerged as a promising therapeutic target for cancer therapy. Elevated lactate levels and acidic pH within the tumor microenvironment (TME) resulting from glycolytic profoundly impact various cellular populations, including macrophage reprogramming and impairment of T-cell functionality. Altogether, the Warburg effect has been shown to promote tumor progression and immunosuppression through multiple mechanisms. This review provides an overview of the current understanding of the Warburg effect in cancer and its implications. We summarize recent pharmacological strategies aimed at targeting glycolytic enzymes, highlighting the challenges encountered in achieving therapeutic efficacy. Additionally, we examine the utility of the Warburg effect as an early diagnostic tool. Finally, we discuss the multifaceted roles of lactate within the TME, emphasizing its potential as a therapeutic target to disrupt metabolic interactions between tumor and immune cells, thereby enhancing anti-tumor immunity., The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), the ISCIII, FIS (PI22/00130), BBVA (CAIMI), and Cellex Foundation.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Targeting the Warburg Effect in Cancer: Where Do We Stand?

  • Carrillo-Bosch, Laura
  • Barba, Ignasi
  • Seoane, Joan
Warburg effect; Aerobic glycolysis; Tumor metabolism, Efecto Warburg; Glucólisis aeróbica; Metabolismo tumoral, Efecte Warburg; Glucòlisi aeròbica; Metabolisme tumoral, The Warburg effect, characterized by the preferential conversion of glucose to lactate even in the presence of oxygen and functional mitochondria, is a prominent metabolic hallmark of cancer cells and has emerged as a promising therapeutic target for cancer therapy. Elevated lactate levels and acidic pH within the tumor microenvironment (TME) resulting from glycolytic profoundly impact various cellular populations, including macrophage reprogramming and impairment of T-cell functionality. Altogether, the Warburg effect has been shown to promote tumor progression and immunosuppression through multiple mechanisms. This review provides an overview of the current understanding of the Warburg effect in cancer and its implications. We summarize recent pharmacological strategies aimed at targeting glycolytic enzymes, highlighting the challenges encountered in achieving therapeutic efficacy. Additionally, we examine the utility of the Warburg effect as an early diagnostic tool. Finally, we discuss the multifaceted roles of lactate within the TME, emphasizing its potential as a therapeutic target to disrupt metabolic interactions between tumor and immune cells, thereby enhancing anti-tumor immunity., The study was undertaken with the support of the Fundación Asociación Española contra el Cáncer (AECC), the ISCIII, FIS (PI22/00130), BBVA (CAIMI), and Cellex Foundation.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Patient-derived preclinical models to develop immunotherapies

  • Seoane, Joan
Immuno-oncology; Preclinical models; Tumor microenvironment, Inmuno-oncología; Modelos preclínicos; Microambiente tumoral, Immuno-oncologia; Models preclínics; Microambient tumoral, Cancer immunotherapy has revolutionized the treatment of some malignancies. Yet, many tumors do not unfortunately respond to immune-based therapies. Deeper insights into the biology of the immune response to cancer are required to identify novel therapeutic targets and advance immuno-oncology. To do so, we need to study cancer in patient-derived models that can faithfully recapitulate and capture the complexity and heterogeneity of the tumor immune ecosystem. Platforms facilitating the analysis of the human tumor immune microenvironment of individual patients are crucial. Patient-derived models are fundamental not only to better understand the biology of the cancer immune system but also to discern the mechanism of action of therapeutic compounds and perform preclinical studies toward improving the success of subsequent clinical testing. In this viewpoint, I present a brief review of patient-derived models for cancer immunotherapy., Fundación Asociación Española Contra el Cáncer (AECC). Cellex Foundation. BBVA (CAIMI). ISCIII FIS. Grant Number: PI22 00130